Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Director · EXECUTIVE CHAIRMAN | November 10, 2021 | December 08, 2021 |
| CATERPILLAR INCCAT · Entity 2808 | Director | March 01, 2022 | March 02, 2022 |
| MCDONALDS CORPMCD · Entity 2849 | Director | December 31, 2025 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date November 10, 2021 · Filed December 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 3,092,852 |
Ending reported balance
After 2021-11-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-11-10 · Gift · Disposed 693 · Balance 3,103,252 Row 2 · 2021-11-12 · Gift · Disposed 10,400 · Balance 3,092,852 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 35,789 |
Reported balance
Holding disclosure · report date 2021-11-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 35,789 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021.
CATERPILLAR INC
Report date March 01, 2022 · Filed March 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,382 |
Reported balance
After 2022-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-01 · Tax withholding · Disposed 293 · Balance 8,382 F1: Includes adjustments for dividends accrued. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes adjustments for dividends accrued.
MCDONALDS CORP
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 23,286.12 |
Reported balance
After 2025-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-31 · Grant · Acquired 670.75 · Balance 23,286.12 F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan"). F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F4: Includes shares acquired through dividend reinvestment. |
| Common StockSEC Table I · non-derivative | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan").
F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation.
F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board.
F4: Includes shares acquired through dividend reinvestment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,400 | $72.52 | $391,608.00 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 22 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,163,599 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 64,374 | $72.52 | $4,668,080.61 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 21 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,168,999 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,961 | $72.51 | $142,192.11 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 20 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,233,373 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,859 | $72.51 | $279,796.80 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 19 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,235,334 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,700 | $72.50 | $340,750.00 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 18 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,239,193 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,683 | $72.50 | $919,454.09 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 17 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,243,893 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,400 | $72.49 | $101,486.00 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 16 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,256,576 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,463 | $72.49 | $540,955.56 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,257,976 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $72.48 | $65,232.00 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,265,439 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 61 | $72.48 | $4,420.98 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,266,339 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 518 | $72.47 | $37,536.87 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,266,400 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 210 | $72.46 | $15,216.60 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,266,918 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,147 | $72.46 | $372,925.89 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,267,128 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,000 | $72.45 | $217,350.00 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,272,275 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,800 | $72.45 | $130,401.00 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,275,275 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 856 | $72.44 | $62,008.64 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,277,075 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,401 | $72.44 | $246,351.44 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,277,931 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,600 | $72.43 | $478,038.00 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,281,332 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,716 | $72.43 | $413,981.30 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,287,932 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,674 | $72.42 | $410,911.08 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,293,648 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 10,177 | $72.42 | $736,967.46 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,299,322 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,345 | $72.41 | $531,851.45 |
DisclosureSEC source: 0001179110-18-013324 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,309,499 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 119 | $72.60 | $8,638.81 |
DisclosureSEC source: 0001179110-18-013325 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,134,185 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $72.59 | $36,295.00 |
DisclosureSEC source: 0001179110-18-013325 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,134,304 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,900 | $72.59 | $210,496.50 |
DisclosureSEC source: 0001179110-18-013325 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,134,804 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $72.58 | $29,032.00 |
DisclosureSEC source: 0001179110-18-013325 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,137,704 Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,600 | $72.58 | $116,120.00 |
DisclosureSEC source: 0001179110-18-013325 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,138,104 Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 20:29 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantPhantom Stock Units · Derivative | 280 | $151.74 | $42,487.20 |
DisclosureSEC source: 0000018230-18-000269 · wf-form4_153842573391998.xml · derivative · entry 1 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,795 Underlying: Common Stock · 280 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the economic equivalent of one share of Caterpillar Inc. common stock. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: The phantom stock units were acquired under the Caterpillar, Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F3 · derivative.expiration_date: The phantom stock units were acquired under the Caterpillar, Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 21:44 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantPhantom Stock Units · Derivative | 311 | $136.72 | $42,519.92 |
DisclosureSEC source: 0000018230-18-000212 · wf-form4_153065426951672.xml · derivative · entry 1 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,461 Underlying: Common Stock · 311 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the economic equivalent of one share of Caterpillar Inc. common stock. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation F3 · derivative.exercise_date: The phantom stock units were acquired under the Caterpillar Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F3 · derivative.expiration_date: The phantom stock units were acquired under the Caterpillar Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| June 06, 2018 Filed Jun 7, 2018 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 23,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008228 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,134,185 Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 23:51 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantPhantom Stock Units · Derivative | 289 | $147.17 | $42,532.13 |
DisclosureSEC source: 0000018230-18-000122 · wf-form4_152271306501556.xml · derivative · entry 1 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,112 Underlying: Common Stock · 289 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the economic equivalent to one share of Caterpillar Inc. common stock. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation F3 · derivative.exercise_date: The phantom stock units were acquired under the Caterpillar, Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F3 · derivative.expiration_date: The phantom stock units were acquired under the Caterpillar, Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 00:07 UTC | CATERPILLAR INC CAT · Entity 2808 | Tax withholdingCommon Stock | 549 | $153.33 | $84,178.17 |
DisclosureSEC source: 0000018230-18-000098 · wf-form4_152046760699875.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,757 F1 · shares: Represents shares withheld from the reporting person to satisfy tax obligations arising from the vesting of restricted stock units granted on March 6, 2017. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:07 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantCommon Stock | 993 | $0.00 | $0.00 |
DisclosureSEC source: 0000018230-18-000098 · wf-form4_152046760699875.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,306 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 53,462 | $60.55 | $3,237,124.10 |
DisclosureSEC source: 0001179110-18-003319 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,158,108 Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 23:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 688,073 | $0.00 Strike: $59.94 | $0.00 |
DisclosureSEC source: 0001179110-18-002511 · edgar.xml · derivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688,073 Underlying: Common shares · 688,073 shares Expires 2028-02-15 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 229,358 on 02/16/2019, 229,357 on 02/16/2020, and 229,358 on 02/16/2021. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 23:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 125,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002511 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,211,570 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 17:37 UTC | MCDONALDS CORP MCD · Entity 2849 | GrantPhantom Stock · Derivative | 987.68 | $172.12 | $169,999.48 |
DisclosureSEC source: 0001140361-18-000350 · doc1.xml · derivative · entry 2 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,637.45 Underlying: Common Stock · 987.68 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the "Plan"). F2 · kind: Acquisition of phantom stock pursuant to the Plan in transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3 · derivative.exercise_date: Payment of phantom stock may be deferred until the earlier of (a) April of the year following the Director's retirement date or other termination from the Board; or (b) a specific future date pursuant to an election. F3 · derivative.expiration_date: Payment of phantom stock may be deferred until the earlier of (a) April of the year following the Director's retirement date or other termination from the Board; or (b) a specific future date pursuant to an election. F4 · balance_after: Includes shares acquired through dividend reinvestment. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 19:53 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantPhantom Stock Units · Derivative | 269 | $158.00 | $42,502.00 |
DisclosureSEC source: 0000018230-18-000014 · wf-form4_151500918844270.xml · derivative · entry 1 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,784 Underlying: Common Stock · 269 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is equivalent to one share of Caterpillar Inc. common stock. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: The phantom stock units were acquired under the Caterpillar, Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F3 · derivative.expiration_date: The phantom stock units were acquired under the Caterpillar, Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| December 22, 2017 Filed Jan 5, 2018 22:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-000645 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,086,445 Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015654 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,086,430 Read SEC document |
| December 14, 2017 Filed Dec 19, 2017 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 36,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015654 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,086,885 Read SEC document |
| December 13, 2017 Filed Dec 19, 2017 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 23,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015654 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,123,237 Read SEC document |
| December 13, 2017 Filed Jan 5, 2018 22:46 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 22,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-000644 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,123,692 F1 · shares: Due to an administrative error, the shares gifted on December 13, 2017 were overreported by 455 shares. Read SEC document |
| December 12, 2017 Filed Dec 19, 2017 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015654 · edgar.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 9,992 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 12, 2017 Filed Dec 19, 2017 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015654 · edgar.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 9,978 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 12, 2017 Filed Dec 19, 2017 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015654 · edgar.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 0 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 12, 2017 Filed Dec 19, 2017 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015654 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 9,752 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 12, 2017 Filed Dec 19, 2017 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015654 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 9,738 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 12, 2017 Filed Dec 19, 2017 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015654 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 720 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 12, 2017 Filed Dec 19, 2017 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015654 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,146,582 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.